- Home
- CLDI vs PZG Comparison
CLDI vs PZG Comparison
Compare CLDI & PZG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- PZG
- Stock Information
- Founded
- CLDI 2014
- PZG 1992
- Country
- CLDI United States
- PZG United States
- Employees
- CLDI N/A
- PZG N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- PZG Metal Mining
- Sector
- CLDI Health Care
- PZG Basic Materials
- Exchange
- CLDI Nasdaq
- PZG Nasdaq
- Market Cap
- CLDI 10.2M
- PZG 41.2M
- IPO Year
- CLDI N/A
- PZG 1999
- Fundamental
- Price
- CLDI $0.57
- PZG $0.67
- Analyst Decision
- CLDI
- PZG
- Analyst Count
- CLDI 0
- PZG 0
- Target Price
- CLDI N/A
- PZG N/A
- AVG Volume (30 Days)
- CLDI 41.9M
- PZG 336.8K
- Earning Date
- CLDI 08-12-2025
- PZG 05-12-2025
- Dividend Yield
- CLDI N/A
- PZG N/A
- EPS Growth
- CLDI N/A
- PZG N/A
- EPS
- CLDI N/A
- PZG N/A
- Revenue
- CLDI N/A
- PZG N/A
- Revenue This Year
- CLDI N/A
- PZG N/A
- Revenue Next Year
- CLDI N/A
- PZG N/A
- P/E Ratio
- CLDI N/A
- PZG N/A
- Revenue Growth
- CLDI N/A
- PZG N/A
- 52 Week Low
- CLDI $0.20
- PZG $0.31
- 52 Week High
- CLDI $3.89
- PZG $0.78
- Technical
- Relative Strength Index (RSI)
- CLDI 57.42
- PZG 63.62
- Support Level
- CLDI $0.23
- PZG $0.68
- Resistance Level
- CLDI $1.60
- PZG $0.76
- Average True Range (ATR)
- CLDI 0.16
- PZG 0.04
- MACD
- CLDI 0.05
- PZG 0.00
- Stochastic Oscillator
- CLDI 26.62
- PZG 63.96
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About PZG Paramount Gold Nevada Corp.
Paramount Gold Nevada Corp is an exploration-stage mining company. Together with its subsidiaries, the company is engaged in the business of acquiring, exploring, and developing precious metal projects in the United States. Also, it explores for gold and silver. The company enhances the value of projects by implementing exploration and engineering programs that are likely to expand and upgrade known mineralized material to reserves. Its projects include sleeper gold, grassy mountain gold, frost project, other non-material, and others.